相关实验视频

Updated: Jun 12, 2025

Assays for the Identification of Novel Antivirals against Bluetongue Virus

Assays for the Identification of Novel Antivirals against Bluetongue Virus

Published on: October 11, 2013

针对登革热病毒包膜蛋白治疗药物的基于片的设计和药理模拟

Dwaipayan Chaudhuri¹, Satyabrata Majumder¹, Joyeeta Datta¹

¹Department of Life Sciences, Presidency University, 86/1 College Street, Kolkata, 700073 India.

In silico pharmacology

|September 23, 2024

概括

研究人员通过确定kanamycin作为一个有前途的分子,为登革热病毒 (一种Flavivirus) 设计了新的治疗方法. 这种基于结构的药物设计为控制登革热病毒感染提供了新的方向.

科学领域:

病毒学病毒学
药物发现药物发现药物发现
计算化学计算化学

背景情况:

登革热病毒 (Flavivirus) 是一种主要的热带传染病,没有特定的治疗方法,导致显著的死亡率.
目前对登革热病毒感染的管理仅依赖于症状缓解.

研究的目的:

使用基于结构的方法设计针对登革热病毒的新型小分子治疗方法.
为了确定针对登革热病毒包膜蛋白受体结合域的潜在候选药物.

主要方法:

使用基于碎片和基于药的药物设计方法.
用于验证的分子动力学 (MD) 模拟,结合能量的计算和ADMET分析.

主要成果:

卡纳米辛被确定为一种稳定的结合分子,可以对抗登革热病毒包膜蛋白受体结合域.
模拟后分析证实了高结合能和可纳米的稳定相互作用.

结论:

该研究成功地确定了kanamycin作为对登革热病毒的潜在治疗剂.
这项研究为基于结构和基于碎片的登革热病毒治疗设计开辟了新的途径.
这些发现为开发小分子疗法以控制登革热病毒感染提供了方向.

关键词:

接收人接收人登革热病毒包裹蛋白质是登革热病毒的包裹蛋白质.基于片段的新药设计.模拟MD和能源分析.药类模型的建模.

更多相关视频

High-throughput Antiviral Assays to Screen for Inhibitors of Zika Virus Replication

High-throughput Antiviral Assays to Screen for Inhibitors of Zika Virus Replication

Published on: October 30, 2021

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

相关概念视频

Drug Discovery: Overview

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...

Structure-Activity Relationships and Drug Design

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...